化疗时HRQoL较低,化疗后有所改善。再加上在ALINA中观察到的DFS益处,这些数据支持阿来替尼作为ALK NSCLC切除术患者的重要辅助治疗。 inhibitors (TKI
mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and PD(L)-1inhibitors (IO
to EGFR Inhibitors in Lung Cancer. Cancer Discov. 2014;4(9):1046-1061.内容来源:阿斯利康中国